-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Calidi Biotherapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2022 to 2024.
- Calidi Biotherapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$4.03M, a 59% increase year-over-year.
- Calidi Biotherapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$21.8M, a 24.9% increase year-over-year.
- Calidi Biotherapeutics, Inc. annual Operating Income (Loss) for 2024 was -$21.8M, a 24.9% increase from 2023.
- Calidi Biotherapeutics, Inc. annual Operating Income (Loss) for 2023 was -$29M, a 25.4% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)